ZA791525B - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- ZA791525B ZA791525B ZA791525A ZA791525A ZA791525B ZA 791525 B ZA791525 B ZA 791525B ZA 791525 A ZA791525 A ZA 791525A ZA 791525 A ZA791525 A ZA 791525A ZA 791525 B ZA791525 B ZA 791525B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/892,714 US4192944A (en) | 1978-04-03 | 1978-04-03 | Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA791525B true ZA791525B (en) | 1980-11-26 |
Family
ID=25400392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA791525A ZA791525B (en) | 1978-04-03 | 1979-03-30 | Therapeutic agents |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4192944A (it) |
| JP (1) | JPS54141797A (it) |
| BE (1) | BE875246A (it) |
| CA (1) | CA1117112A (it) |
| CH (1) | CH643256A5 (it) |
| DE (1) | DE2913295A1 (it) |
| DK (1) | DK153485C (it) |
| FR (1) | FR2423490A1 (it) |
| GB (1) | GB2019836B (it) |
| IE (1) | IE48278B1 (it) |
| IT (1) | IT1116537B (it) |
| LU (1) | LU81107A1 (it) |
| NL (1) | NL7902444A (it) |
| SE (1) | SE440652B (it) |
| ZA (1) | ZA791525B (it) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4495189A (en) * | 1975-11-27 | 1985-01-22 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | Condensed pyrimidines |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
| CA1157858A (en) | 1979-12-03 | 1983-11-29 | Ikuo Ueda | Quinazoline derivatives |
| IE51802B1 (en) * | 1979-12-03 | 1987-04-01 | Fujisawa Pharmaceutical Co | Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them |
| JPS63183581A (ja) * | 1985-10-03 | 1988-07-28 | Tokyo Tanabe Co Ltd | ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬 |
| HU201551B (en) * | 1988-02-03 | 1990-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same |
| US6295995B1 (en) * | 2000-04-07 | 2001-10-02 | Irene D. Ewaka | Permanently covered rigid or semi-rigid mounting piece for an article of fashion |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3072485A (en) * | 1960-08-24 | 1963-01-08 | Eastman Kodak Co | Optically sensitized azido polymers for photomechanical resist compositions |
| AT299212B (de) * | 1966-11-02 | 1972-06-12 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen |
| US3960847A (en) * | 1972-04-17 | 1976-06-01 | E. R. Squibb & Sons, Inc. | 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof |
| US3929787A (en) * | 1974-04-22 | 1975-12-30 | Squibb & Sons Inc | 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones |
| US4017625A (en) * | 1975-08-01 | 1977-04-12 | Pfizer Inc. | Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor |
| SU685156A3 (ru) * | 1975-08-01 | 1979-09-05 | Пфайзер Инк (Фирма) | Способ получени -(5-тетразолил(1-оксо-1н-пиримидо-)1,2-а) хинолин-2-карбоксамида |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
| US4122274A (en) * | 1977-05-25 | 1978-10-24 | Bristol-Myers Company | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
-
1978
- 1978-04-03 US US05/892,714 patent/US4192944A/en not_active Expired - Lifetime
-
1979
- 1979-03-15 GB GB7909146A patent/GB2019836B/en not_active Expired
- 1979-03-29 FR FR7907971A patent/FR2423490A1/fr active Granted
- 1979-03-29 NL NL7902444A patent/NL7902444A/xx not_active Application Discontinuation
- 1979-03-29 DK DK130079A patent/DK153485C/da active
- 1979-03-30 CA CA000324712A patent/CA1117112A/en not_active Expired
- 1979-03-30 BE BE0/194348A patent/BE875246A/xx not_active IP Right Cessation
- 1979-03-30 ZA ZA791525A patent/ZA791525B/xx unknown
- 1979-04-02 SE SE7902915A patent/SE440652B/sv not_active IP Right Cessation
- 1979-04-02 LU LU81107A patent/LU81107A1/xx unknown
- 1979-04-02 IT IT48569/79A patent/IT1116537B/it active
- 1979-04-03 CH CH310379A patent/CH643256A5/de not_active IP Right Cessation
- 1979-04-03 JP JP3942779A patent/JPS54141797A/ja active Granted
- 1979-04-03 DE DE19792913295 patent/DE2913295A1/de active Granted
- 1979-08-08 IE IE950/79A patent/IE48278B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT1116537B (it) | 1986-02-10 |
| DK153485C (da) | 1988-11-21 |
| BE875246A (fr) | 1979-10-01 |
| CH643256A5 (de) | 1984-05-30 |
| DK153485B (da) | 1988-07-18 |
| FR2423490B1 (it) | 1982-03-19 |
| GB2019836A (en) | 1979-11-07 |
| GB2019836B (en) | 1982-06-03 |
| IE790950L (en) | 1979-10-03 |
| SE440652B (sv) | 1985-08-12 |
| NL7902444A (nl) | 1979-10-05 |
| US4192944A (en) | 1980-03-11 |
| JPS6256874B2 (it) | 1987-11-27 |
| FR2423490A1 (fr) | 1979-11-16 |
| IE48278B1 (en) | 1984-11-28 |
| DK130079A (da) | 1979-10-04 |
| DE2913295A1 (de) | 1979-10-18 |
| CA1117112A (en) | 1982-01-26 |
| SE7902915L (sv) | 1979-10-04 |
| IT7948569A0 (it) | 1979-04-02 |
| JPS54141797A (en) | 1979-11-05 |
| LU81107A1 (fr) | 1979-11-07 |
| DE2913295C2 (it) | 1988-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA796708B (en) | Therapeutic agents | |
| ZA801328B (en) | Therapeutic agents | |
| GB2000136B (en) | Therapeutic agents | |
| GB2005248B (en) | Therapeutic agents | |
| GB2000138B (en) | Therapeutic agents | |
| ZA80298B (en) | Therapeutic agents | |
| GB2000131B (en) | Therapeutic agents | |
| EG16606A (en) | Therapeutic agents | |
| ZA792390B (en) | Therapeutic agents | |
| GB2013181B (en) | Therapeutic agents | |
| GB2004876B (en) | Therapeutic agents | |
| GB2019836B (en) | Therapeutic agents | |
| GB2007656B (en) | Therapeutic agents | |
| ZA796959B (en) | 5-aryl-4-isoxazolecarboxylate-safening agents | |
| GB2011890B (en) | Therapeutic agents | |
| GB2000510B (en) | Therapeutic agents | |
| GB2047691B (en) | Therapeutic agents | |
| GB2053910B (en) | Pyridylaminotriazole therapeutic agents | |
| GB2011891B (en) | Therapeutic agents | |
| GB2013179B (en) | Therapeutic agents | |
| GB2010824B (en) | Therapeutic agents | |
| GB2007654B (en) | Therapeutic agents | |
| GB2008104B (en) | Therapeutic agents | |
| GB2000441B (en) | Therapeutic agents | |
| GB2009156B (en) | Therapeutic agents |